We have developed the Breath Biopsy platform, using breath analysis for precision medicine and the early detection of disease.

74.2

Toggle

ALPHA SCORE

74.2

MOMENTUM

NaN

MARKET

NaN

INNOVATION

NaN

MONEY

NaN

Market Capitalisation$

Last$ 58.00 M

Total$ 136.26 M

Viewed

Appeared in SearchNA

Ventures > Owlstone Medical

Owlstone Medical

We have developed the Breath Biopsy platform, using breath analysis for precision medicine and the early detection of disease.

Partners:

Merck KGaA, Merck KGaA, Merck KGaA, Merck KGaA, Merck KGaA

View All